dealmaking

Life Sciences M&A Surges in 2026: A Definitive Analysis of Record-Breaking Dealmaking, Private Equity Shifts, and Complex CVR Structures

The global life sciences sector has officially entered a robust new era of mergers and acquisitions, shattering prior performance ceilings…